Variable effects of human and canine polymorphonuclear leucocytes on vascular smooth muscle tone

Cardiovascular Research

Volumn 26, Issue 8, 1992, Pages 751-756

  Gonzales, J ^a   Mehta, J L ^a   Lawson, D L ^a   Nichols, W W ^a   Nicolini, F A ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Femoral artery; Leukotrienes; Nitric oxide; Polymorphonuclear leucocytes; Superoxide radicals

Indexed keywords

7 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY) 2 HYDROXYPROPOXY] 4 OXO 8 PROPYL 4H 1 BENZOPYRAN 2 CARBOXYLIC ACID; INDOMETACIN; N(G) METHYLARGININE; NITRIC OXIDE; OXYHEMOGLOBIN; PIRIPROST; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; HUMAN; HUMAN TISSUE; LEUKOCYTE; MUSCLE TONE; NONHUMAN; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

ANIMAL; ARGININE; ARTERIES; CHROMONES; DOGS; ENDOTHELIUM; HUMAN; INDOMETHACIN; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NEUTROPHILS; NITRIC OXIDE; OMEGA-N-METHYLARGININE; OXYHEMOGLOBINS; PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; SPECIES SPECIFICITY; SRS-A; SUPEROXIDE DISMUTASE; TISSUE CULTURE;

EID: 85047678639     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1093/cvr/26.8.751     Document Type: Article

References (26)

1. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365–76.
2. Mehta JL, Nichols WW, Donnelly WH, et al. Protection by superoxide dismutase from myocardial dysfunction and attenuation of vasodilator reserve following coronary occlusion and reperfusion in dog. Circ Res 1989;65:1238–95.
3. Werns SW, Shea MJ, Lucchesi BR. Free radicals and myocardial injury: pharmacologic implications. Circulation 1986;74:1–5.
4. Zweir JL, Rayburn BK, Flaherty JT, Weisfeldt ML. Recombinant superoxide dismutase reduces oxygen free radical concentrations in reperfused myocardium. J Clin Invest 1987;80:1723–34.
5. 4. J Am Coll Cardiol 1985;6:1047–51.
6. 4 synthesis by polymorphonuclear leukocytes. J Biol Chem 1986;261:16466–72.
7. Rimele TJ, Sturm RJ, Adams LM, et al. Interaction of neutrophils with vascular smooth muscle: identification of a neutrophil-derived relaxing factor. J Pharmacol Exp Ther 1988;245:102–11.
8. Mehta JL, Lawson DL, Nichols WW. Mehta P. Modulation of vascular tone by neutrophils: dependence on endothelial integrity. Am J Physiol 1989;257:H1315–20.
9. Salvemini D, deNucci G. Gryglewski RJ, Vane JR. Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor. Proc Natl Acad Sci USA 1989;86:6328–32.
10. McCall TB, Boughton-Smith NK, Palmer RMJ, Whittle BJR, Moncada S. Synthesis of nitric oxide by neutrophils. Release and interaction with superoxide anion. Biochem J 1989;261:293–6.
11. Ignarro LJ, Buga GM, Woods KS, Byrns RE. Chaudhary G. Endothelium-derived relaxing factor from artery and vein is nitricoxide. Proc Natl Acad Sci USA 1987;84:9265–9.
12. Ohlstein EH, Nichols AJ. Rabbit polymorphonuclear neutrophils elicit endothelium-dependent contraction in vascular smooth muscle. Circ Res 1990;65:917–24.
13. Sessa WC, Mullane KM. Release of a neutrophil-derived vasoconstictor agent which augments platelet-induced contractions of blood vessels in vitro. Br J Pharmacol 1990;99:553–9.
14. Nishida M, Kuzuya T, Noshida S, et al. Polymorphonuclear leukocytes induced vasoconstriction in isolated canine coronary arteries. Circ. Res 1990;66:253–8.
15. Mehta JL, Nichols WW, Goldman R. Prostacyclin release following endoperoxide analog infusion in the intact dog. Am J Physiol 1984;246:R205–10.
16. Mehta JL, Mehta P. Ward MB, Lawson DL. Inhibition of human platelet and neutrophil function by piriprost (U 60, 257). Prostaglandins Leukotrienes Med 1987;29:259–67.
17. Dinerman JL, Mehta JL. Endothelial, platelet and leukocyte interactions in ischemic heart disease. J Am Coll Cardiol 1990;16:207–22.
18. Mehta JL, Coker B, Lawson DL, Martin TD, Mayfield WR, Staples ED. Polymorphonuclear leukocytes differentially relax human internal mammary artery and saphenous vein segments. Coronary Art Dis 1991;2:379–88.
19. Nicolini FA. Wilson AC, Mehta P, Mehta JL. Comparative platelet inhibitory effects of human neutrophils and lymphocytes. J Lab Clin Med 1990;116:147–52.
20. Gryglewski RJ, Palmer RMJ, Moneada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986;320:454–6.
21. Rubanyi GM, Vanhoutte PM. Superoxide anion and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986;250:H822–7.
22. Dinerman JL, Lawson DL, Mehta JL. Interactions between nitroglycerin and endothelium in vascular smooth muscle relaxation. Am J Physiol 1990;260:H698–701.
23. Wright LD, Mulsch A, Busse A, Osswald A. Generation of nitric oxide by human neutrophils. Biochem Biophys Res Commun 1989;160:813–9.
24. Lawson DL, Mehta JL, Nichols WW, Mehta P, Donnelly WH. Superoxide radical-mediated endothelial injury and vasoconstriction of rat thoracic aortic rings. J Lab Clin Med 1990;115:541–8.
25. 4 potentiates the contractile effects of epinephrine and norepinephrine on rat aortic rings. J Pharmacol Exp Ther 1988:247:953–7.
26. Mehta JL, Nichols WW. Leukotriene receptor antagonist FPL 55712 and t-PA-induced thrombolysis in canine coronary thrombosis. Thromb Res 1990;58:13–21.